Showing results (91-100 of 225) with videos related to

Sort By:
Pageof 23
Harefuah|May 16, 1993
[Prognosis of acute myocardial infarction in the elderly. SPRINT Study Group]D Gilat, U Goldbourt, H Reicher-Reiss, et al.
Cardiovascular Drugs and Therapy|July 4, 1998
Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine TrialH Reicher-Reiss, S Behar, V Boyko, et al.
Cardiovascular Drugs and Therapy|July 4, 1998
Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarctionM Jonas, U Goldbourt, V Boyko, et al.
Archives of Internal Medicine|February 8, 1993
Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 StudyU Goldbourt, S Behar, H Reicher-Reiss, et al.
The American Journal of Medicine|April 1, 1993
Infarct site-related mortality in patients with recurrent myocardial infarction. SPRINT Study GroupY Moshkovitz, S Sclarovsky, S Behar, et al.
International Journal of Cardiology|January 8, 1999
The outcome of patients with a first non-Q wave acute myocardial infarction presenting with ST segment depression, ST segment elevation, or no ST deviations on the admission electrocardiogramM Haim, M Benderley, H Hod, et al.
Annals of Internal Medicine|July 1, 1992
Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study GroupM Eldar, Z Sievner, U Goldbourt, et al.
Cardiology|October 12, 1999
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-upE Z Fisman, A Tenenbaum, M Benderly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study GroupM Benderly, E Graff, H Reicher-Reiss, et al.
International Journal of Cardiology|April 3, 1999
Are coronary patients at higher risk with digoxin therapy? An ongoing controversyH Reicher-Reiss, M Jonas, V Boyko, et al.
Pageof 23